PAR 4.55% 23.0¢ paradigm biopharmaceuticals limited..

Ann: POSITIVE TOP-LINE RESULTS FROM PRECLINICAL STUDY IN ARDS, page-54

  1. 145 Posts.
    lightbulb Created with Sketch. 27
    My thoughts exactly Beaza. While this is a positive announcement and has much potential, it is another road that will need to be developed and have money poured into it. Now, that being said, I don't want PAR to be a one trick pony but for me I want PR and the team laser focused on getting the IND a green light. We don't want to run out of funds and face possible dilution. We need to achieve revenue. Given the current SP, any further delays to the IND is going to cause some serious pain.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.0¢
Change
0.010(4.55%)
Mkt cap ! $80.45M
Open High Low Value Volume
22.8¢ 23.3¢ 22.5¢ $46.92K 203.9K

Buyers (Bids)

No. Vol. Price($)
1 337 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 138166 5
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.